Celgene shareholders, rejoice — you’ve been given a way out, analysts say

Most analysts on Thursday can agree on one thing: Bristol-Myers Squibb Co.’s agreement to acquire Celgene Corp. is a win for Celgene’s shareholders.

source http://www.marketwatch.com/news/story.asp?guid=%7B12262DCA-0F71-11E9-B960-B6816F33771B%7D&siteid=rss&rss=1

Comment or Tag a Friend!

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.